Levis W R, Lanza A P, Swersie S, Meeker H C, Schuller-Levis G B, Bardin C W
Lepr Rev. 1989 Jun;60(2):94-101. doi: 10.5935/0305-7518.19890012.
Luteinizing hormone (LH), follicle-stimulating hormone (FSH) and testosterone levels were determined by radioimmunoassay (RIA) in leprosy patients and analysed for effect of disease classification, disease activity and duration of disease. LH and FSH levels were found to be significantly elevated in lepromatous patients compared to borderline-lepromatous, midborderline and borderline-tuberculoid patients. A positive correlation was seen between LH and FSH and a negative correlation was seen between testosterone and both LH and FSH. No correlation was seen between hormone levels and measures of disease activity: bacillary index and IgM to phenolic glycolipid I, a Mycobacterium leprae antigen. A significant correlation was seen between duration of disease and FSH when age was taken into account, indicating that testicular dysfunction is probably cumulative and irreversible. It is recommended that LL patients be routinely screened for hypogonadism using FSH, LH and testosterone levels.
采用放射免疫分析法(RIA)测定麻风患者的促黄体生成素(LH)、促卵泡生成素(FSH)和睾酮水平,并分析疾病分类、疾病活动度和病程对其的影响。结果发现,与界线类偏瘤型、中间界线类和界线类偏结核型患者相比,瘤型患者的LH和FSH水平显著升高。LH和FSH之间呈正相关,睾酮与LH和FSH均呈负相关。激素水平与疾病活动度指标(细菌指数和针对麻风杆菌抗原酚糖脂I的IgM)之间无相关性。在考虑年龄因素时,病程与FSH之间存在显著相关性,这表明睾丸功能障碍可能具有累积性且不可逆。建议对瘤型患者常规筛查性腺功能减退情况,检测FSH、LH和睾酮水平。